Intracranial pressure (ICP) monitoring is a diagnostic test that accurately measures the pressure inside the head directly by using a small pressure-sensitive probe injected through the skull. It also helps the doctors to determine if any low or high cerebrospinal fluid (CSF) pressure is causing the symptoms. Based on Technique, the Invasive Intracranial Pressure Monitoring segment led the market in 2020 with a share of around 80.9% & in terms of the region; North America showed its dominance in the market with a share of around 37.64%. However, the Asia-Pacific region held the fastest growth rate in the market, with a good CAGR value of 7.67%.
New York, United States, May 25, 2022 (GLOBE NEWSWIRE) -- The research specialists from Strategic Market Research have delineated that the Market for Intracranial Pressure Monitoring was worth USD 1.3 billion in 2020. It is predicted to reach a remarkable benchmark of around USD 2.37 billion by 2030, with a CAGR of nearly 6.2 % throughout the forecasted time frame. Let us make you accustomed to the pivotal statics provided below.
To get a first-hand overview of the report, Request a Sample at
The report laid out by Strategic Market Research on Intracranial Pressure Monitoring Market is classified based on:
· Invasive Intracranial Pressure Monitoring
External Ventricular Drainage (EVD)
Microtransducer ICP Monitoring
· Non-invasive Intracranial Pressure Monitoring
Transcranial Doppler Ultrasonography
Tympanic Membrane Displacement
Optic Nerve Sheath Diameter
Traumatic Brain Injury (TBI)
Malignant Cerebral Infarction (MCI)
Ambulatory Surgical Centers
Rest of North America
Rest of Europe
Rest of APAC
Rest of LAMEA
Make a Direct Purchase of the latest intracranial pressure monitoring market Report published in the month of January 2022. Click the below link to initiate the purchase:
Key Factors boosting the Market Growth:
· The major factor responsible for the propulsion of the market is the continuous increase in people suffering from various neurological illnesses. In one of its surveys, BIAA (the Brain Injury Association of America) asserted that a brain injury occurs every nine seconds in the USA, thus resulting in approximately 3.5 million injuries per year.
· Apart from the rise of neurological illnesses, the loss of skull elasticity and the rise of traumatic brain injuries (TBI) due to broken skull bones also influence the market growth. BIAA (the Brain Injury Association of America) elucidated that around 2.8 million people in the U.S suffer from TBI each year, out of which around 280,000 people require hospitalization. On the other hand, CDC reported that, in 2020, there were around 176 deaths per day in the USA due to TBI and people who were more than 75 years old constituted nearly 28% of the overall fatality rates.
· Moreover, the rise in the number of road accidents across the globe are also proliferating the market growth to a great extent. The World Health Organization has stated that more than 1.3 million people die from road accidents each year.
In terms of Techniques, the ‘Invasive Intracranial Pressure Monitoring’ Segment dominated the market Comprehensively in 2020.
By Techniques, the market is segregated into Invasive Intracranial Pressure Monitoring (External Ventricular Drainage (EVD), Microtransducer ICP Monitoring), and Non-invasive Intracranial Pressure Monitoring ( Tympanic Membrane Displacement, Transcranial Doppler Ultrasonography,Optic Nerve Sheath Diameter, MRI/CT, and Others). The ‘Invasive Intracranial Pressure Monitoring’ segment held the most significant market share of around 80.9% in 2020 because of the rise in the probability of aortic fragility, cerebral amyloid angiopathy (CAA), hemodynamic instability, as well as the unpredictability associated with the hypothermic CPB with nonpulsatile blood flow. The National Library of Medicine stated that cerebral amyloid angiopathy (CAA) has become more common with the rise in age, and 50% of the population above the age of 70 have CAA. Moreover, the risk rate of cerebral bleeding is seven out of 10.
In terms of Applications, the Traumatic Brain Injury (TBI) segment dominated the Market Growth in 2020
For Applications, the market has been broadly ramified into Traumatic Brain Injury (TBI), Hydrocephalus, Subarachnoid haemorrhage, Cerebral Edema, Malignant Cerebral Infarction (MCI), Intracerebral Haemorrhage, CNS infections, and others). The ' Traumatic Brain Injury (TBI)' segment held the highest market share of approximately 26.8%. Due to TBI, the intracranial pressure increases, & it can be accurately detected with the help of an intraparenchymal pressure monitor that drives the need for these devices worldwide, which in turn is fuelling the growth of this segment. The CDC has stated that approximately 5.3 million men, women, & children in the United States live with a permanent TBI-related disability.
By End-User, the ‘Hospital’ Segment held the most Significant Market Share.
Based on End-User, the market has been broadly divided into Hospitals, Trauma Centers, Ambulatory Surgical Centers, & Neurosurgery Centers. The ' Hospitals' held the most significant market share in 2020. The availability of the highly advanced ICP devices and the increase of patient admissions per year are driving the growth of this segment widely across the globe.
Moreover, the Trauma centers held the fastest growth rate throughout the estimated period of 2020-2030. The continuous rise in demand for multi-disciplinary emergency medical services is augmenting this segment's growth. Besides that, the trauma surgeons undergo advanced training for adequately handling the trauma cases that are critical and invasive. As per the US Department of Veteran Affairs, almost 6 out of every ten men (or 60%) & 5 out of every ten women (or 50%) experience at least one trauma condition in their lifetime.
North America continued its Sheer Dominance in the Intracranial Pressure Monitoring Market:-
On a regional basis, North America was regarded as the most dominant region in 2020, with an overall share of around 37.64%. The rising cases of TBI is the major factor that is driving the market growth extensively in this region. The Brain Trauma Foundation has asserted that traumatic brain injury (TBI) is a leading cause of mortality in the USA, accounting for nearly 30% of fatalities.
However, due to the tremendous prospects of the market participants to build their presence in countries like China and India, the Asia Pacific is by far the most focused & fastest-growing region, with a CAGR of around 7.67 %.
Before initiating a purchase, make a Pre-order enquiry and get a detailed overview of the content of the report.
The list of Pertinent Players prevailing in the Intracranial Pressure Monitoring Market is as follows:
Integra Lifesciences Corporation
Natus Medical Incorporated
Spiegelberg GmbH & Co
Gaeltec devices Ltd
Focus Medical Group Inc.
Headsense Medical Inc.
Kindly go through and get access to our comprehensive coverage of myriad number of healthcare reports published in the last three months:
· On 23rd June 2021, Epipole, a video retinal imaging organization, proposed a project called Eurostar worth €1.1 million, to develop a technology solution for the diagnosis of intracranial pressure (ICP). This Eurostar project would combine Statumanu’s AI software with Epipole’s handheld video ophthalmoscope technology, which can easily assess the images of the blood vessels present in the retina to provide instant assessment & continuous monitoring of the changes in ICP.
· On 8th June 2021, a group of Brazilian researchers validated the various non-invasive intracranial pressure monitoring methods and stated that high BP is one of the major causes of increased intracranial pressure. Based on this, they proposed a highly effective treatment for intracranial pressure. FAPESP supported this research study, and it also involved the collaboration between the researchers at Sao Paulo State University (UNESP) & Brain4care.
· On 14th April 2021, NovaSignal Corp. announced the launching of its NovaGuideTM 2 Platform, which provided the physicians with crucial, real-time information regarding the cerebral blood flow to help in guiding the ICP diagnosis procedures & improving the patient outcomes.
SMR’s ‘Spinal Implants and Surgery Devices Market Report Insights & Forecast 2030’ explains a 360-degree view of the detailed market insights like its key drivers, restraints, opportunities, etc. In 2020, the Spinal Implants and Surgery Devices Market was worth USD 10.86 billion. It is assumed to reach a landmark of around USD 16.33 billion by 2028, with a stable CAGR of 5.23 %. The rising prevalence of traumatic fractures, Spondylolisthesis, chronic degenerative disc disease, scoliosis, and other spinal instability problems is driving the overall market growth. The essential players involved in the market are Globus Medical, Abbott Laboratories, Orthofix Medical, B. Braun (B. Braun Holding GmbH & Co. KG), Zimmer Biomet Holdings, Medtronic, Boston Scientific, Depuy Synthes (Johnson & Johnson), Stryker Corporation, etc.
SMR’s ‘Brain Monitoring Market Report Insights & Forecast 2030’ delivers an outstanding concept regarding the crucial market insights like drivers, restraints, opportunities, etc. The Brain Monitoring Market size is estimated to reach around USD 8.0 billion by 2028, from USD 5.4 billion in 2020, expediting at a healthy CAGR of around 7.2%. The continuous rising cases of neurological disorders worldwide, the increase in applications of minimally invasive & non-invasive devices in the healthcare sectors are propelling the market’s growth forward. The pivotal organizations that are prevailing in the market are Natus Medical, Inc., Nihon Kohden Corporation, Philips Healthcare, Ge Healthcare, Siemens Healthineers, Medtronic, Edwards Lifesciences, Spiegelberg Gmbh & Co. Kg., etc.
SMR’s ‘Intravascular Temperature Management Market Report Insights & Forecast 2030’ elucidates a clear-cut concept of the essential market insights like drivers, restraints, opportunities, etc. The total share of the Global Intravascular Temperature Management Market was valued at up to USD 268.13 billion. It is anticipated to reach USD 405.81 billion by 2030, representing a CAGR of around 4.14 %. The key factors that are responsible for the proliferation of the market growth are the continuous surge in cardiovascular diseases, surgical procedures, & a rise in awareness of the usage of the intravascular temperature devices. The key players that are associated with this market are Smiths Group Plc, ZOLL Medical, 3M Company, Belmont Instrument, Biegler, Stihler Electronic GmbH, BD Company, The 37Company, etc.
SMR’s ‘Neurovascular Devices Market Report Insights & Forecast 2030’ caters to a concrete idea on the various market insights like drivers, restraints, opportunities, etc. In 2020, the Global Neurovascular Devices Market share accounted for up to USD 2.6 billion. It is forecasted to reach around USD 5.21 billion by 2030, with a CAGR of 8.6 percent. The pivotal factors that are continuously propelling the market growth are the increase in the investments in R&D activities due to the continuous rise in cases of neurological diseases. Also, the essential players that are associated with this market are Johnson & Johnson Services, and Penumbra. Inc, Micro Port Scientific Corporation, Terumo Corporation, etc.
SMR’s ‘Central Nervous System (CNS) Biomarkers Market Report Insights & Forecast 2030’ highlights a complete idea about the dynamic market insights like drivers, restraints, opportunities, etc. In 2020, the overall market share of the Global Central Nervous System (CNS) Biomarkers Market accounted for up to USD 3.67 billion. It is expected to reach a remarkable landmark of USD 8.7 billion by 2030, with a CAGR of approximately 9.0 % throughout the prevised time frame. The vital factors that are expediting the market growth are the continuous increase in the number of neurological illnesses and the rise of funds by the government for promoting the R&D activities. Apart from that, the key players in this market are Avacta Group plc, Diagenetic Asa, Banyan Biomarkers, Avid Radiopharmaceuticals Inc., Acumen Pharmaceuticals Inc., Siemens AG, etc.
SMR’s ‘Neuroendoscopy Market Insights & Forecast Report 2030’ highlights a clear idea about the various market insights like drivers, opportunities, restraints, etc. In 2020, the Global Neuroendoscopy Market was worth USD 176.51 million. It is estimated to reach around USD 314.44 million in 2030, with a CAGR of 5.94%. The notable factors driving the market growth forward are the rising occurrences of various diseases, an increase in the demand for Minimally Invasive Surgical Procedures, & higher success rates. Also, the crucial organizations that are associated with the market are Envigo, JANVIER LABS, Taconic Biosciences Inc., Biomedical Research Models (Biomere), Transpogen Biopharmaceutical, Inc.
Strategic Market Research facilitates the organizations globally in taking pivotal business decisions by furnishing the Syndicated and Customized Research Reports, which are highly precise in terms of market numbers. We believe that every firm, whether it is a startup which is in the Introduction stage of the Product Life cycle or an established one which is at the growth stage, requires market research services in order to streamline its key business blueprint. It may be related to Product Launch, Go to Market strategies, Competitive Analysis or new geographical penetration and expansion.
Strategic Market Research LLP.
Press Release: https://www.strategicmarketresearch.com/press-releases